ePoster Submission
Submission deadline: Thursday, 20 September 2018
Please note that abstracts accepted as "ePosters only" will be displayed on terminals during the congress. However they will not be presented at a specific session. In addition all ePosters will be available on the ECTRIMS Online Library.
For your references please find below the ePoster numbers.
ePoster numbers
| ePoster Number | Abstract Title | First name | Last name |
|---|---|---|---|
| EP1291 | Diagnostic value of enhancing lesions on post-contrast T1-weighted magnetic resonance images in patients with a clinically isolated syndrome | María | Díaz Sánchez |
| EP1292 | The role of IgG index versus oligoclonal bands in patients with suspected multiple sclerosis | Pål | Berg-Hansen |
| EP1293 | Clinically isolated syndrome: natural course and diagnostic criteria | Mafalda | Seabra |
| EP1294 | Autonomic nervous system dysfunction in people with neuromyelitis optica spectrum disorders | Luka | Crnosija |
| EP1295 | Russian cohort of patients with NMO and NMO spectrum disorders | Taras | Simaniv |
| EP1296 | Establishing the diagnosis of multiple sclerosis in Croatian patients with clinically isolated syndrome: 2010 versus 2017 McDonald criteria | Mario | Habek |
| EP1298 | Application of the Matthews's criteria to differentiate MS from NMOSD at disease onset in a Latin American cohort | Edgar | Carnero Contentti |
| EP1299 | Brucellosis presenting as a longitudinally extensive transverse myelitis | Bassem | Yamout |
| EP1300 | Experts' opinion on 2nd-line treatments failure criteria for patients with multiple sclerosis | Jérôme | De Sèze |
| EP1301 | Recurrent myelitis with CLIPPERS imaging: a case report | Kamilla D'Aveiro | Fernandez |
| EP1302 | Challenges in diagnosing OCB-negative MS - the importance of imaging | Anne-Marie | Landtblom |
| EP1303 | Neurosarsoidosis: report of 30 cases. What about diagnosis dilemma? | Clément | Richard |
| EP1304 | Safety of rituximab in NMOSD patients: a long time prospective observational study | Vahid | Shaygannejad |
| EP1305 | The clinical spectrum of MOG antibody-associated demyelination: a retrospective case study | Athanasios | Papathanasiou |
| EP1306 | Clinical characterization of patients suffering from both central and peripheral demyelinating autoimmune disorder | Juliane | Klehmet |
| EP1307 | Clinical and imaging features of 14 patients with tumefactive multiple sclerosis | Maria Victoria | Castro Sanchez |
| EP1308 | Tocilizumab after autologous hematopoietic stem cell transplantation in refractory neuromyelitis optica: a case report | Chiara Rosa | Mancinelli |
| EP1309 | MS mimics; MRI-negative relapsing-remitting autoimmune encephalomyelitis, hidden in the psychogenic disorders population | Daiki | Takewaki |
| EP1310 | Impact of cigarette and hookah smoking on NMOSD patients´ disability status | Masoud | Etemadifar |
| EP1311 | Neuromyelitis optica spectrum disorder in third level hospitals of Ecuador | Edgar Patricio | Correa Díaz |
| EP1312 | A longitudinal study of cognitive function in a Japanese cohort of NMO and MS | Takahiro | Wakasugi |
| EP1313 | Early relapse after rituximab initiation in a patient with neuromyelitis optica spectrum disease and side effects to subsequent tozilizumab therapy: need for further treatment options? | Ingrid | Meinl |
| EP1314 | Successful intravenous immunoglobulin treatment in a patient with relapsing MOG antibody-associated disease | Elena | Tsantes |
| EP1315 | Familial multiple sclerosis | Habtany | Youness |
| EP1316 | Baló's concentric sclerosis: study of clinico-radiological characteristics and therapeutic outcomes | Ioannis | Tzartos |
| EP1317 | Clinical and demographic characteristics of relapsing-remitting multiple sclerosis in Kazakhstan | Sairan | Kozhakanova |
| EP1318 | Retinal nerve fiber layer and ganglion cell inner plexiform layer in youth with serum myelin oligodendrocyte glycoprotein antibody positivity | E. Ann | Yeh |
| EP1319 | Diagnostic value of oligoclonal bands in children: a Danish nationwide multicenter population-based cohort study | Magnus Spangsberg | Boesen |
| EP1320 | Fatigue, depression and quality of life in children with multiple sclerosis: a French cohort study | Kumaran | Deiva |
| EP1321 | Decreased thickness of peripapillar retinal nerve fiber layer may be present after years of the episode in some patients with pediatric acute disseminated encephalomyelitis | Gemma | Olivé-Cirera |
| EP1322 | Differences in cerebrospinal fluid CXCL8, CXCL10, CXCL13 and MCP1 chemokines levels in paediatric clinically isolated syndrome and definitive multiple sclerosis | Hana | Nohejlova |
| EP1323 | The challenges of predicting the future after the first inflammatory CNS event in pediatric patients | Bruna | Klein da Costa |
| EP1324 | Pediatric acquired demyelination syndromes profile in a Brazilian center | Renata Barbosa | Paolilo |
| EP1326 | The usefulness of evoked potentials in the initial diagnosis of multiple sclerosis in children | Izabela | Witek |
| EP1327 | Clinical trials in pediatric multiple sclerosis : a British-French patient and parent perspective | Justine | Marie dit Calais |
| EP1328 | Efficacy of therapy in pediatric MS during 2 years (single-site study) | Maria | Shumilina |
| EP1329 | What changes with the 2017 McDonald criteria in CIS pediatric patients | Bruna | Klein da Costa |
| EP1331 | Two pediatric cases of Anti-NMDA receptor encephalitis with MS-typical lesions | Lydia | Marcus |
| EP1332 | Clinical observation and treatment approaches of child Devic opticomyelitits in Kazakh | Aigerim | Galym |
| EP1333 | Cognitive and psychiatric problems as the first manifestation of multiple sclerosis in children | Małgorzata | Bilska |
| EP1334 | Analysis of longitudinal free-living features from wearable biosensors in multiple sclerosis patients | Cindy | Gonzalez |
| EP1335 | Unmet needs of patients transitioning to secondary progressive multiple sclerosis: qualitative findings for a resource development | Alessandra | Solari |
| EP1336 | Predictors for conversion of radiologically isolated syndrome to multiple sclerosis | Irem | Çiftçi |
| EP1337 | Upper extremity function and its relation with ambulatory impairment in multiple sclerosis | Caspar E.P. | van Munster |
| EP1338 | Initial MRI lesion load: a predictor of long-term disability independent of suggestive event | Antoine | Gueguen |
| EP1339 | Exploring the outcome of multiple sclerosis (MS) among Saudi adult patients: a single-centered cross-sectional study at King Abdulaziz Medical City (KAMC) | Ahmad | Abulaban |
| EP1340 | Mental health status among children of mothers diagnosed with multiple sclerosis: a Danish cohort and register-based study | Johanna Balslev | Andersen |
| EP1341 | Burden of multiple sclerosis in Eastern Mediterranean Region: findings from the 2016 Global Burden of Disease study | Mohammad Ali A. | Sahraian |
| EP1342 | Treatment patterns of multiple sclerosis patients treated with disease-modifying therapies in Puerto Rico | Lobat | Hashemi |
| EP1343 | Temporal trends on the incidence of multiple sclerosis in Santiago de Compostela (Spain) | Eva | Costa Arpín |
| EP1344 | Validity and reliability of multiple sclerosis minimum data set form for national registry system in Iran | Sharareh | Eskandarieh |
| EP1345 | Clinical characteristics and personality traits influence how people with MS look for medical information | Virginia | Meca-Lallana |
| EP1346 | Mastery is significantly associated with greater physical and mental health-related quality of life in two independently recruited international samples of people with multiple sclerosis | Steve | Simpson, Jr. |
| EP1347 | Use of mobile health technology in establishment of multiple sclerosis (MS) registry in Iran: a study of stakeholders' attitude | Omid | Beiki |
| EP1348 | Epidemiology of multiple sclerosis in Ardabil, northwest of Iran | Negar | Molazadeh |
| EP1349 | Clinico-demographic characterization of a large cohort of neurological patients referred to the neuro-immunology outpatient clinic of Columbia University Medical Center | Claire | Riley |
| EP1350 | Does socio-economic status influence early diagnosis and access to MS services? | Holly | Lyle |
| EP1351 | High prevalence area of multiple sclerosis in the far west of Algeria | Zahira | Barka bedrane |
| EP1352 | The impact of stigma in people with primary progressive multiple sclerosis | Francesc | Pérez-Miralles |
| EP1353 | Epidemiology of multiple sclerosis in the Highlands of Scotland: prevalence, incidence and mortality | Francisco Javier | Carod-Artal |
| EP1354 | Time to get proper diagnosis in multiple sclerosis and start disease-modifying therapy: the Highlands MS incidence study | Francisco Javier | Carod-Artal |
| EP1355 | Prevalence of multiple sclerosis in Cuenca, Ecuador | Edgar Patricio | Correa Díaz |
| EP1356 | Pattern of demyelinating disorders in a tertiary medical center in India | Anup | Thacker |
| EP1357 | Early versus late start of vitamin D supplementation in multiple sclerosis predicts short term disease course: a two-year observational study | Paolo | Ragonese |
| EP1358 | A descriptive study of switching patterns among MS patients who started on Glatopa therapy: a claims database analysis | Jessica | Alexander |
| EP1359 | The OFSEP high definition cohort: to prognosticate the evolution of multiple sclerosis at clinical key steps of the disease | Romain | Casey |
| EP1360 | Use of anxiety and depression treatment in Hispanic multiple sclerosis patients of San Juan MS Center | Astrid | Diaz |
| EP1361 | Characteristics of multiple sclerosis patients treated with disease-modifying therapies in Puerto Rico | Lobat | Hashemi |
| EP1362 | Female to male ratio trend of multiple sclerosis in Tehran, Iran | Sharareh | Eskandarieh |
| EP1363 | The role of heavy metals in genesis of multiple sclerosis in the population of various districts of Tashkent city | Gulshanbonu | Suyunova |
| EP1364 | The study of the gender value of the degree of asthenic syndrome according to the test "SAM" in patients with multiple sclerosis | Yulduz | Parpiyeva |
| EP1365 | Exclusive breastfeeding does not affect postpartum exacerbations | Maria | Shumilina |
| EP1366 | Rebound in disease activity after fingolimod suspension for pregnancy planning: predictor factors | Maria | Sepulveda |
| EP1367 | Cesarean section in women with MS: a choice or a need? | Laura | De Giglio |
| EP1368 | The presence of MR-activity before and after pregnancy is associated with the probability of postpartum exacerbations | Maria | Shumilina |
| EP1369 | Effects of sex-related factors on probability of disability in women with multiple sclerosis | Ilknur | Hosgel |
| EP1370 | Pregnancy outcomes in Chilean MS patients receiving interferon beta or glatiramer acetate: a longitudinal 8 year study | Bernardita | Soler |
| EP1371 | Workplace difficulties, health-related quality of life and perception of stigma in people with multiple sclerosis with low physical disability | José M | García-Domínguez |
| EP1372 | Autonomic nervous system dysfunction is an independent contributor to multiple sclerosis related fatigue | Luka | Crnosija |
| EP1373 | Persons with MS are at increased risk of osteopenia and osteoporosis. A ten-year longitudinal study | Margitta T | Kampman |
| EP1374 | Sexual dysfunction in patients with multiple sclerosis: association with disability, anxiety, depression and fatigue | Edgar | Carnero Contentti |
| EP1375 | Quality of life and SR-fampridine in multiple sclerosis patients | Nathalie | Derache |
| EP1376 | Evolution of afferent trigeminal system involvement in patients with clinically isolated syndrome over two-year follow-up | Tereza | Gabelic |
| EP1377 | Association between cognitive functions, balance, and walking in persons with multiple sclerosis with minimal disability | Hatice | Ayan |
| EP1378 | Risk factors associated with falls in persons with multiple sclerosis: an observational study | Zuhal | Abasiyanik |
| EP1380 | Physician- and patient-derived sources of error estimating prevalence of pseudobulbar affect in an academic multiple sclerosis referral center | John R. | Rinker |
| EP1381 | Reverse takotsubo cardiomyopathy in the setting of active multiple sclerosis lesion involving the medulla oblongata | Frédéric | London |
| EP1382 | Management of multiple sclerosis - related trigeminal neuralgia in Italian centres | Diana | Ferraro |
| EP1383 | Cognitive function as measured by SDMT is associated with employment status in an Australian MS cohort | Jeannette | Lechner-Scott |
| EP1384 | Factors related to restless leg syndrome in multiple sclerosis | Asiye Tuba | Ozdogar |
| EP1385 | Fatigue and related factors in persons with multiple sclerosis | Cavid | Babayev |
| EP1386 | Speech profile of multiple sclerosis patients admitted to a neurorehabilitation unit | María Laura | Saladino |
| EP1387 | Benign multiple sclerosis patients display increased prevalence of sleep disorders | Recai | Türkoğlu |
| EP1388 | Tracking symptom impact in MS patients: longitudinal study of symptoMScreen scores in patients attending two large tertiary MS centers | Ilya | Kister |
| EP1389 | The effect of spasticity on the walking speed and quality of life in patients with multiple sclerosis | Judit | Füvesi |
| EP1390 | Predictors of long term disability progression in patients with relapsing remitting multiple sclerosis | Valentina | Ignatova |
| EP1391 | The effect of the decrease in walking distance and speed on the quality of life and activities of daily living in patients with multiple sclerosis | Judit | Füvesi |
| EP1392 | Sleep disorders sub-estimated during multiple sclerosis - study of a series of Algerian patients | Barka Bedrane | zahira |
| EP1393 | Translation in "Arab" and "Moroccan dialect" adaptation and validation of the modified fatigue impact scale during multiple sclerosis | Habtany | Youness |
| EP1394 | Short-term effects of inpatient multidisciplinary rehabilitation in multiple sclerosis: clinical predictors from a large-scale, single-center study | Elisabetta | Groppo |
| EP1395 | Treatment burden in multiple sclerosis | Maria Celica | Ysrraelit |
| EP1396 | SCOPOUSEP: a predictive model for scoring the severity of relapses in multiple sclerosis | Laure | Michel |
| EP1397 | Validation study of the MS-COG-e scale at 60 seconds cut-off point. A new electronic and brief neuropsychological scale to detect cognitive impairment (CI) in patients with multiple sclerosis (MS) | Jose Eustasio | Meca Lallana |
| EP1398 | Longitudinal assessment of upper limb function by an engineered glove reveals a deterioration not captured by the EDSS over 7 years in patients with multiple sclerosis | Caterina | Lapucci |
| EP1399 | Social functioning with regard to impact of the disease in the patients with multiple sclerosis | Anna | Pokryszko-Dragan |
| EP1400 | Validity and potential added value of multi-domain computerized cognitive assessment for patients with multiple sclerosis | Daniel | Golan |
| EP1401 | Factors associated with falls in multiple sclerosis | Raminta | Macaitytė |
| EP1402 | Upper limb function in MS: correlation between instrumental and clinical scale | Claudio | Solaro |
| EP1403 | Pilot Study of Telemedicine in multiple sclerosis to evaluate the effectiveness of a telecommunication system for the detection of the clinical activity of the disease in the number of relapses with respect to the standard clinical practice. TELEM | Anna | Gil |
| EP1404 | Coping in multiple sclerosis: qualitative analysis of themes | Carolyn A. | Young |
| EP1405 | Fatigue, patient reported outcomes, and sleep apnea in people with multiple sclerosis: perception is insufficient to just sleep on it | Jared | Srinivasan |
| EP1406 | Multiple sclerosis and EDSS: a closer inspection of the Walking Scale finds erratic walking | Jared | Srinivasan |
| EP1407 | Assessment of cognitive function in early stages of multiple sclerosis. Validation of BICAMS in Norway | Ellen | Skorve |
| EP1408 | A preliminary investigation into the relationship between the Multiple Sclerosis Walking Scale (MSWS-12) and an objective multi-dimensional digital gait analysis | Mark | Gudesblatt |
| EP1409 | Making precision medicine work at the bedside without a universal health record: the MS BioScreen experience | Riley | Bove |
| EP1410 | Validation of the Spanish version of the Treatment Burden Questionnaire in multiple sclerosis patients | Marcela Paula | Fiol |
| EP1411 | Reliability and validity of the activities-specific Balance Confidence scale and Fall Efficacy Scale-International in Iranian patients with multiple sclerosis | Saeideh | Monjezi |
| EP1412 | Evaluation of changes in cognitive function as assessed by NeuroTrax in patients with multiple sclerosis treated with natalizumab for up to 5 years | Mark | Gudesblatt |
| EP1413 | Rapid foot-tapping but not hand-tapping ability distinguishes between multiple sclerosis subtypes | Sumire | Sato |
| EP1414 | Evolution of dysautonomia in patients with clinically isolated syndrome over two-year follow-up | Ivan | Adamec |
| EP1415 | Do you exercise regularly? Psychometric analysis of a single question for assessing physical activity in people with multiple sclerosis | Turhan | Kahraman |
| EP1416 | Value of the MoCA test to detect cognitive impairment in MS patients without subjective cognitive complaints | Isabelle | Rouleau |
| EP1417 | Timely intervention, monitoring and education MATTERS in multiple sclerosis (TIME MATTERS in MS): developing a globally applicable quality improvement tool | Jeremy | Hobart |
| EP1418 | Upper limb function in MS: creation of a normative data set on subjective and objective measures and the construction of an MS-specific assessment tool | Claudio | Solaro |
| EP1419 | Hope in multiple sclerosis: qualitative analysis of concepts and domains | Carolyn A. | Young |
| EP1420 | Multi-domain analysis of cognitive impairment in people with multiple sclerosis (PwMS): relationship of the number of cognitive domains impaired ( | Mark | Gudesblatt |
| EP1421 | Investigation into the relationship between digital brain volume and computerized screening assessment of cognitive function in people with multiple sclerosis: objective analytics to quantify disease impact | Mark | Gudesblatt |
| EP1422 | Investigation into the relationship between patient reported disease severity (MSIS-29) and a multi-domain objective computerized screening cognitive analysis aattery in people with multiple sclerosis | Mark | Gudesblatt |
| EP1424 | Reliability, validity and responsiveness of the timed 360⁰ turn test in multiple sclerosis | Fatih | Söke |
| EP1425 | A new test for the measuring balance in multiple sclerosis: psychometric evaluation of the Static Balance Test | Fatih | Söke |
| EP1426 | MMP-9 activity dynamics in relapsing-remitting multiple sclerosis patients under natalizumab treatment and their relationship to JCV reactivation and T-lymphocyte phenotypes | Maria Antonella | Zingaropoli |
| EP1427 | Relationship between upper and lower limb impairments objectively assessed in people with multiple sclerosis | Giancarlo | Coghe |
| EP1428 | Quality of life and some features of social functioning in multiple sclerosis | Gulshanbonu | Suyunova |
| EP1429 | Impact of multiple sclerosis on the occupational status in developing countries. An experience in Argentina | Judith | Steinberg |
| EP1430 | The value of multiple sclerosis caregiver burden scale. An Argentinean population | Judith | Steinberg |
| EP1431 | Development of the adaptive, bilingual multiple sclerosis Health Resource Survey (MS-HRS) | Rocco | Haase |
| EP1432 | Work related and quality of life consequences of early multiple sclerosis | Jorge | Correale |
| EP1433 | Impact of socioeconomic level on the employment status of people with multiple sclerosis | Natalia | Ciufia |
| EP1434 | Decreasing emergency department utilization in a multiple sclerosis patient-centered specialty practice: an advanced multimodal approach | Susan | Stuart |
| EP1435 | Reduced sick leave in multiple sclerosis after switch from first-line disease-modifying drugs (interferon beta or glatirameracetat) to fingolimod | Anne | Wickström |
| EP1436 | Driving continuous improvement of MS care quality - initial launch experience from the first continuous quality improvement research learning health system in multiple sclerosis-The Multiple Sclerosis Continuous Quality Improvement (MS-CQI) | Brant | Oliver |
| EP1437 | Burden of multiple sclerosis in Brazil | Gisela | Kobelt |
| EP1438 | Employment status in patients with multiple sclerosis: a cross-sectional study in Argentina | Edgar | Carnero Contentti |
| EP1439 | New oral treatments decrease the switch to second-line therapies in multiple sclerosis. A 9-years retrospective, clinical and budget impact study | Augustin | Oterino Duran |
| EP1440 | The neuro-opthalmological evaluation of multiple sclerosis' and neuromyelitis optica's optic neuritis: analysis of 238 cases | Fethi | Idiman |
| EP1441 | Evaluation of pupillary response characteristics measured by pupillometry in differentiating MS from NMOSD with the machine-learning approach: a potential pupillary pattern recognition method | Sara | Samadzadeh |
| EP1442 | Characteristics of optic neuropathy in Behcet´s disease | Gulsen | Akman-Demir |
| EP1443 | Developmental venous anomalies are more common in patients with multiple sclerosis & clinically isolated syndrome: co-incidence or clinically relevant? | Patrick | Kruczek |
| EP1444 | Comorbidities and safety of use of MD1003 in a cohort of patients with progressive multiple sclerosis | Cecile | Donze |
| EP1445 | Prevalence of cancer and the relationship to disease-modifying treatments in a cohort of multiple sclerosis patients over 50 years of age | Irene | Moreno Torres |
| EP1446 | Double jeopardy of multiple sclerosis and idiopathic Parkinson's disease: three new case reports | Alexander | Scarborough |
| EP1447 | The relationship between migraine and multiple sclerosis therapies | Yesim | Beckmann |
| EP1448 | Pain in AQP4-ab-positive and MOG-ab-positive neuromyelitis optica spectrum disorders | Susanna | Asseyer |
| EP1449 | Multiple sclerosis related headaches. Prevalence and classification | Hatem | Shehata |
| EP1450 | Multiple sclerosis clinical trials: how to encourage patients participation? Results from an observational study conducted via Carenity, a worldwide online patient community | Roman | Dos Santos |
| EP1451 | Monocyte-derived tissue transglutaminase in multiple sclerosis patients: reflecting an anti-inflammatory status of the cells? | Anne-Marie | van Dam |
| EP1452 | RGC-32 regulates TGF-β-induced reactive astrogliosis in a mouse model of multiple sclerosis | Alexandru | Tatomir |
| EP1453 | IL-18 improves the activation of encephalytogenic cells and the induction of adoptively transferred experimental autoimmune encephalomyelitis | Ruth | García Hernández |
| EP1454 | Comparative study of reverse transcriptase polymerase chain reaction and fluorescence-activated cell sorting for quantitating B cells after anti-CD20 monoclonal antibody therapy | Gisbert | Weckbecker |
| EP1455 | A2AR antagonism in acute EAE model leads to early and more severe EAE | Marjo | Nylund |
| EP1457 | Oleanolic acid protects against gastrointestinal disturbances in the experimental autoimmune encephalomyelitis model of multiple sclerosis | Beatriz | Gutierrez |
| EP1458 | Impact of A20 deficiency in myeloid cells: study in a murine model | Serena | Martire |
| EP1459 | Expression of the Nerve Growth Factor and its receptors, TrkA and p75NTR, in the spinal cord in Experimental Autoimmune Encephalomyelitis | Nikolaos | Grigoriadis |
| EP1460 | Difference of tissue-specific networks where the associated genes are densely interconnected between Japanese and European descent patients with MS | Takuya | Matsushita |
| EP1461 | Cross-sectional and longitudinal analysis of clinical parameters in a large-scale, national, multicentric multiple sclerosis cohort and the influence of MC1R SNPs | Patrick | Ostkamp |
| EP1462 | Involvement of NINJ2 in inflammatory activity in MS | Silvia | Peroni |
| EP1463 | A whole-exome sequencing approach in multiplex Italian multiple sclerosis families to identify new genes involved in the disease | Elisabetta | Mascia |
| EP1465 | Functional relevance for CXCR5 variants associated with multiple sclerosis | Elia | Gil-Varea |
| EP1466 | The MS risk variant rs2762943 of the CYP24A1 gene is associated with decreased serum levels of the active form of vitamin D | Elia | Gil-Varea |
| EP1467 | Long noncoding RNA-Ccr2-5As and THRIL as novel prognostic epigenetic biomarkers in patients with multiple sclerosis | Amr | Hassan |
| EP1468 | Multiple sclerosis genetic risk variants correlate with protein expression in monocytes of relapsing remitting patients: a protein quantitative trait loci study | Laura | Ferrè |
| EP1469 | Genome-wide DNA methylation in secondary progressive multiple sclerosis patients reveals unique epigenetic signature | Kira | Groen |
| EP1470 | Circulating miR-320b and miR-421 are deregulated in primary progressive MS patients | María | Muñoz-San Martín |
| EP1471 | Total absence of the dominant HLA-DRB1*15 allele among patients with positive and most frequent HLA-DPB1*03, in a Hellenic cohort with multiple sclerosis | Maria | Anagnostouli |
| EP1472 | Family distribution in multiple sclerosis: a study of the prevalence of familial recurrence in Puerto Rico | Cristina | Rubi |
| EP1473 | A possible association between circulating vitamin D and haptoglobin concentrations in multiple sclerosis patients | Zhila | Maghbooli |
| EP1474 | 360° immune-profiling reveals new pathogenic immune cell subsets in multiple sclerosis: effects of glatiramer acetate | Luca | Battistini |
| EP1475 | The difference of intercellular cytokine profiles among MOG+CNS disorders, AQP4+NMOSD, and MS patients | Jia | Liu |
| EP1476 | Neuromyelitis optica and the role of Foxp3+ regulatory T cells | Livnat | Brill |
| EP1477 | Characterization of the immunophenotye of clinically isolated syndrome patients and conversion to multiple sclerosis | Chieh-Hsin | Lee |
| EP1478 | The contribution of monocytes and the purinergic receptor, P2X7, in MS relapse | Mastura | Monif |
| EP1479 | T cell receptor repertoire in multiple sclerosis patients | Fumie | Hayashi |
| EP1480 | CSF kappa light chain ratios potential prognostic impact in clinically isolated syndrome conversion to multiple sclerosis | Manuel | Salavisa |
| EP1481 | In vitro verification of in silico predicted antigenic properties of intrathecal B cell receptor repertoires - a pilot study | Rune A. | Høglund |
| EP1482 | Could basal levels of B cells and memory B cells identify responders to disease modifying treatments for MS? | Ester | Quintana |
| EP1483 | Vitamin D levels and epidemiology of multiple sclerosis in Spain: Madrid vs Lanzarote | Silvia | Perez Perez |
| EP1484 | Serum levels of leptin and adiponectin are not associated with disease activity or treatment response in multiple sclerosis | Silje Stokke | Kvistad |
| EP1485 | Ditary animal protein sources in relation to risk of neuromyelitis optica spectrum disorder | Nasim | Rezaeimanesh |
| EP1486 | Environmental risk factors for NMO-IgG sero-positivity in neuromyelitis optica spectrum disorder | Sharareh | Eskandarieh |
| EP1487 | Vitamin D and body mass index in Egyptian multiple sclerosis patients | Dina | zamzam |
| EP1488 | Coffee intake and multiple sclerosis disability | Sara | Duarte |
| EP1489 | High dietary carbohydrate to protein ratio as a risk factor for neuromyelitis optica spectrum disorder: a case-control study | Soodeh | Razeghi Jahromi |
| EP1490 | Incidence of multiple sclerosis following bariatric surgery: a case series | Foziah | Alshamrani |
| EP1491 | Diet during adolescence and its association with multiple sclerosis in Bogota, Colombia | Jorge | Patiño |
| EP1492 | Interoception as a neurocognitive mechanism underlying fatigue in multiple sclerosis | Fatima | Pagani Cassara |
| EP1493 | The phosphatase CPI-17 as a regulator of oligodendrocyte degeneration | Newshan | Behrangi |
| EP1494 | Different blood-brain barrier disruption profile in multiple sclerosis, neuromyelitis optica spectrum disorders and neuropsychiatric systemic lupus erythematosus | Alicja | Kalinowska-Lyszczarz |
| EP1495 | NR4A impairment in multiple sclerosis patients: defects in blood and in central nervous system | Francesca | Montarolo |
| EP1496 | Intrathecal syntheis of free light chains of immunoglobulins is associated with brain atrophy in multiple sclerosis | Vladimir | Nazarov |
| EP1497 | Brain atrophy in multiple sclerosis: how patients understand the role of brain atrophy in the management of their MS | Amanda | Montague |
| EP1498 | Corneal confocal microscopy detects progressive axonal degeneration in patients with multiple sclerosis which is progressive | Ioannis Nikolaos | Petropoulos |
| EP1499 | Investigation of astrocytic functions and involvement in remyelination in an animal model of multiple sclerosis | Sonja | Hochmeister |
| EP1500 | Reduced levels of Coco in the sera of patients with RRMS may be related to the insufficient oligodendrogenesis and neurogenesis | Karin | Mausner-Fainberg |
| EP1501 | AZD4547, a potent FGFR inhibitor, regulates myelin gene expression in OLN-93 oligodendrocytes | Bischand | Sharifi |
| EP1502 | Myelin related gene expression in oligodendrocytes is regulated by FGFR inhibition with BGJ398 in vitro | Vinothkumar | Rajendran |
| EP1503 | Brain and deep grey-matter atrophy in relapsing-remitting multiple sclerosis with cortical lesions based on double inversion recovery MRI | M. Andrea | Parra |
| EP1504 | Gray and white matter brain pathology in highly active multiple sclerosis patients | Francisco | Sanchez |
| EP1505 | Multi-modal MRI intensity distributions reveal differences in normal-appearing white matter between MS subtypes | Jordan | Dworkin |
| EP1506 | Radiological characteristics of patients with multiple sclerosis in Egypt | Mohamed | abdelHafeez |
| EP1507 | Cognitive phenotypes in MS: underlying changes in structural connectivity | Elisabeth | Solana |
| EP1508 | High reproducibility and robustness to lesions, but large software and scanner effects for mean upper cervical cord area (MUCCA) measurement in MS | Hugo | Vrenken |
| EP1509 | A magnetoencephalographic investigation of working memory function in MS | Lars | Costers |
| EP1510 | Identifying pathological brain volume loss in individual early MS patients | Roland | Opfer |
| EP1511 | Rapid reduction of lesion accumulation in specific white matter tracts as assessed by lesion mapping in relapsing-remitting MS patients treated with IFN beta-1a | Antonio | Giorgio |
| EP1512 | Quantification of lesion evolution in primary progressive and relapsing remitting MS | Wim | Van Hecke |
| EP1513 | Comparison of 24 month changes in brain volume among long term users of fingolimod versus glatiramer acetate in patients with multiple sclerosis | Justin Morris | Honce |
| EP1514 | Microstructural changes in the mesocorticolimbic fiber pathway may play a role in the comorbid development of fatigue and depression in multiple sclerosis | Miklos | Palotai |
| EP1515 | Structural MRI correlates of PASAT performance in multiple sclerosis | Vanesa | Pytel |
| EP1516 | Longitudinal changes in advanced diffusion MRI of normal-appearing white matter and chronic lesions in ocrelizumab treated relapsing MS | Anika | Wurl |
| EP1517 | Surface-based cortical gray matter correlates of personality traits in multiple sclerosis | Tom | Fuchs |
| EP1518 | The impact of field strength on structural network organization: a comparative study between 3T and 7T in multiple sclerosis patients | Muthuraman | Muthuraman |
| EP1519 | Resting-state functional correlates of social cognition in multiple sclerosis | Renato | Docimo |
| EP1520 | Training a pattern classifier to distinguish cognitive phenotypes in multiple sclerosis | Korhan | Buyukturkoglu |
| EP1521 | Signal mass change as a marker of brain tissue loss in multiple sclerosis patients following immunoablative therapy and autologous hematopoietic stem cell transplantation | Hyunwoo | Lee |
| EP1522 | A deep learning based semantic segmentation framework for multiple sclerosis in MRI | Sidong | Liu |
| EP1523 | Brain atrophy correction in longitudinal neuroimaging analysis of chronic white matter lesions | Sidong | Liu |
| EP1524 | Relationship between cortical grey matter volume and cognitive impairment perception in multiple sclerosis | Giuseppe | Fenu |
| EP1525 | Decreased interhemispheric connectivity in multiple sclerosis | Johan | Baijot |
| EP1526 | A distributed platform for making large scale manual reference datasets for MS lesion segmentation | Soheil | Damangir |
| EP1527 | Identification of cortical and subcortical correlates of cognitive performance in multiple sclerosis using voxel-based morphometry | Vanesa | Pytel |
| EP1528 | Correlation between retinal Optical Coherence Tomography Measures and cognitive/physical disability in patients with early multiple sclerosis: a prospective study | Hala | Darwish |
| EP1529 | The role of optical coherence tomography as a predictor of cognitive impairment in multiple sclerosis | Cláudia | Lima |
| EP1530 | Cross-sectional OCT study of ON and non-ON MS eyes: non-effect of smoking exposure | Mattia | Rosso |
| EP1531 | Expanding access to cognitive screening for individuals with multiple sclerosis: preliminary examination of two free web-based processing speed tests compared to the Symbol Digit Modalities Test | Jagriti | Bhattarai |
| EP1532 | Functional MRI correlations between fatigue and cognitive performance in patients with relapsing remitting MS | Dessislava | Iancheva |
| EP1533 | The impact of psychological resilience on cognitive and physical measures of disability in multiple sclerosis | Sylvia | Klineova |
| EP1534 | Cognitive impairment in multiple sclerosis is reflected by increased susceptibility for sound-induced flash illusion | Yavor | Yalachkov |
| EP1535 | Cognitive-motor interference while walking in people with multiple sclerosis: a potential maker of functional impairment? | Barbara | Postigo-Alonso |
| EP1536 | The relationship between incidental learning and executive functions in relapsing remitting multiple sclerosis patients | Vladimiro | Sinay |
| EP1537 | Decision making under explicit risk and prefrontal and thalamus volumes in multiple sclerosis patients | Yolanda | Aladro Benito |
| EP1538 | Abnormal network connectivity related to social cognition in relapsing remitting multiple sclerosis | Tomas | Labbe |
| EP1539 | Baseline cognitive function of patients with relapsing remitting multiple sclerosis is associated with therapeutic response to natalizumab | Daniel | Golan |
| EP1540 | Social cognition deficits in early multiple sclerosis | Jorge | Correale |
| EP1541 | Impaired natural viewing behaviour reflects cognitive impairment in multiple sclerosis- an eye-tracking study | Johannes | Gehrig |
| EP1542 | Neuropsychological correlates of fatigue in multiple sclerosis | Moussa A. | Chalah |
| EP1543 | Study of the relationship between executive functioning and episodic memory performance in multiple sclerosis using the Test of Memory Strategies | Fabiola | Garcia-Vaz |
| EP1544 | The 15-15 PASAT 3” approach to study congnitive fatigue in multiple sclerosis | Yolanda | Higueras |
| EP1545 | A systematic literature review: the relation between cognitive functioning and work outcomes in patients with multiple sclerosis | Dennis Adrianus Martinus | van Gorp |
| EP1546 | Performance on a digital neuropsychological test battery in individuals with relapsing remitting multiple sclerosis and healthy controls. Normative values | Vladimiro | Sinay |
| EP1547 | Correlation of fatigue with cognitive and emotional variables in a Portuguese group of multiple sclerosis patients | Telma | Miranda |
| EP1548 | Dynamics of cognitive dysfunction profile in patients with multiple sclerosis based on their disease duration | Todor | Kunchev |
| EP1549 | Cognitive performance of RRMS patients at the time of diagnosis: one step before the concept of cognitive impairment | Maddalena | Guandalini |
| EP1551 | Validation of the Brief International Cognitive Assessment for multiple sclerosis (BICAMS) in a Colombian population | Andrea Nicole | Alarcón |
| EP1552 | Spanish adaptation of the multiple sclerosis and vocational accommodations in multiple sclerosis patients | Sandra | Vanotti |
| EP1553 | Alternative splicing in multiple sclerosis: a systematic review of the literature and validation in transcriptome data | Michael | Hecker |
| EP1554 | Expression levels of apoptosis-related molecules in peripheral blood cells of multiple sclerosis patients | Sunny | Malhotra |
| EP1555 | Serum levels of mir-128-3p are associated to clinical course and disease activity in multiple sclerosis | Mattia | Zanoni |
| EP1556 | Biomarker discovery in tears of multiple sclerosis patients: a new vision in medicine? | Marianne | Dor |
| EP1557 | Plasma neurofilaments correlate with disability in progressive multiple sclerosis patients | Diana | Ferraro |
| EP1558 | Collection of tear fluid from multiple sclerosis patients for the investigation of oligoclonal IgG bands | Franziska | Bachhuber |
| EP1559 | Elevation of Chi3l1 in acute disseminated encephalomyelitis: implications in pathogenesis | Sara | Gil-Perotin |
| EP1560 | Longitudinal expression of gluco- and mineralocorticoid receptors and their targets in multiple sclerosis | Clemens | Goedel |
| EP1561 | Sonographic optic nerve sheath diameter versus optic coherence tomography as a biomarker for disability in patients with multiple sclerosis | Amr | Hassan |
| EP1562 | Searching for early CSF biomarkers of primary progressive multiple sclerosis | Damiano | Marastoni |
| EP1563 | The expression in PBMCs of a subset of microRNA is able to differentiate MS patients with lipid-specific oligoclonal IgM bands | Maider | Muñoz-Culla |
| EP1564 | Comparable sNFL levels in a NEDA-3 cohort of RRMS patients irrespective of different immunomodulatory therapies | Johannes | Piepgras |
| EP1565 | Characterizing cytokine changes before and after ocrelizumab infusions and their contribution to infusion related reactions | Ian | Shelton |
| EP1566 | CSF biomarkers of neurodegeration in early multiple sclerosis course | Domizia | Vecchio |
| EP1567 | Serum neurofilament light chain in MS: association with clinical and MRI measures | Emanuela | Oldoni |
| EP1568 | Hemostasis biomarkers in multiple sclerosis | Bakhtigul | Kholmuratova |
| EP1569 | Blood-brain barrier-activation induced by immunoglobulin G in multiple sclerosis | Fumitaka | Shimizu |
| EP1570 | gMS-classifier1 does not predict disability progression in multiple sclerosis | Johannis Adam | van Rossum |
| EP1571 | Characterization of serum neurofilament, a biomarker for axonal damage, in the SYNERGY study as a complement to opicinumab zreatment effect in MS | Ankur | Sharma |
| EP1572 | Multicenter sensory and motor evoked potentials: definition of improvement beyond measurement variability in single subjects | Martin | Hardmeier |
| EP1573 | IgM MOG antibodies associated with cerebral lymphoma and CLIPPERS syndrome | Klaus Jun. | Berek |
| EP1575 | Long-term prognostic value of anti myelin antibodies in multiple sclerosis | Laura | De Giglio |
| EP1576 | Quality controls in biobank samples: effects of pre-analytical factors on blood samples used in gene expression studies | Paola | Valentino |
| EP1577 | Differential effects of dimethyl fumarate on peripheral blood mononuclear cells of relapsing-remitting multiple sclerosis patients and prognostic implications | Alicia | Sánchez Sanz |
| EP1578 | MicroRNAs and their use as biomarkers in clinically isolated syndrome and multiple sclerosis | Jette Lautrup | Frederiksen |
| EP1579 | Circulating microRNAs as biomarkers in multiple sclerosis | Julia | Vistbakka |
| EP1580 | Looking for prognostic factors in MS: the simultaneous absence of IgGOB and spinal cord lesions at diagnosis identifies a less aggressive disease course | Marco | Puthenparampil |
| EP1581 | The link between epigenetic regulators, neurotrophins and treatment efficacy in patients with multiple sclerosis | Fatih | Söke |
| EP1582 | Siponimod increases brain-derived neurotrophic factor (BDNF) levels in cortical neuronal cultures and naïve healthy mice | Anna | Schubart |
| EP1583 | Explaining long-term depletion of memory B lymphocytes after cladribine treatment | Benjamin | Jacobs |
| EP1584 | Alemtuzumab in highly active MS: effectiveness in real life and the need of immunological profiling | Nicola | De Rossi |
| EP1585 | Switching inactive MS patients under BRACE therapies to teriflunomide due to injection-related problems | Filipa | Ladeira |
| EP1586 | Comparison of fingolimod and teriflunomide on the basis of relapse, magnetic resonance imaging and cognition following the switch from injectables in patients with stable multiple sclerosis | Serkan | Ozakbas |
| EP1587 | Long-term remission of tumefactive relapsing multiple sclerosis after alemtuzumab rescue treatment in an adolescent patient | Pietro | Annovazzi |
| EP1588 | Cyclophosphamide in multiple sclerosis: a real-life study on 222 patients | Pacôme | Constant Dit Beaufils |
| EP1589 | Patient initiation of fingolimod treatment in younger patients with multiple sclerosis in clinics and in the Gilenya@Home Program | John | Osborne |
| EP1590 | Effects of MS treatments on the phenotypic and functional characteristics of B cells | Thomas | Guerrier |
| EP1591 | Synthesis and preliminary testing of siRNA targeting the T Cell receptor β-chain - A proposed therapy for the treatment of autoimmunity | Nicholas | Magazine |
| EP1592 | Characterization of myelin peptide-coupled red blood cells | Muriel | Hohmann |
| EP1593 | Dissection of the distinct susceptibility of hematopoietic precursors and immune cells to cladribine | Antonio | Uccelli |
| EP1594 | Multiple sclerosis relapse resolution with corticosteroid alternatives: a retrospective claims analysis of us health plan data | Tzy-Chyi | Yu |
| EP1595 | Peginterferon beta-1a every 2 weeks demonstrated better clinical outcomes than glatiramer acetate once-daily in patients with RRMS: propensity score matching of phase 3 data from ADVANCE and CONFIRM | Thomas F. | Scott |
| EP1596 | Ocrelizumab in an expanded cohort of primary progressive MS patients: safety outcomes and clinical/paraclinical follow-up | Giovanni | Novi |
| EP1597 | Efficacy of teriflunomide in a progressive multiple sclerosis cohort in the CLIMB study | James | Stankiewicz |
| EP1598 | Real-world data on alemtuzumab treatment of relapsing multiple sclerosis: a two-year prospective one center study | Sofia | Sandgren |
| EP1599 | Effect of RAM589.555 on viability, proliferation and expression of brain derived neurotrophic factor of primary mouse microglia and astrocytes in vitro | Rina | Zilkha-Falb |
| EP1600 | Evaluation of efficacy of glatiramer acetate treatment for multiple sclerosis in Japan | Tomoko | Okamoto |
| EP1601 | Disease modifying treatments (DMTs) in Germany - changes in treatment patterns | Alexander | Stahmann |
| EP1602 | Disease-modifying therapy of paediatric onset multiple sclerosis. A nationwide Danish cohort study | Melinda | Magyari |
| EP1603 | Skin warts during fingolimod treatment in patients with multiple sclerosis | Maya | Zeineddine |
| EP1604 | A new place for mitoxantrone in the treatment of multiple sclerosis | Łukasz | Rzepiński |
| EP1605 | Teri-CARE study design and baseline characteristics of the full study population: assessing changes in quality of life in teriflunomide-treated patients | Guillermo | Izquierdo |
| EP1606 | Teriflunomide reduces spontaneous lymphoproliferation of peripheral blood mononuclear cells from patients with human T-lymphotropic virus (HTLV)-1-associated myelopathy/tropical spastic paraparesis | Yoshimi | Akahata |
| EP1607 | Anti-inflammatory responses by oral administration of iNKT cell ligand OCH in healthy human and multiple sclerosis: results of investigator-initiated, first-in-human phase 1 study | Wakiro | Sato |
| EP1608 | Neuroblastoma cell line and lymphocytes talk for cladribine influenced apoptosis and inflammation pathways in multiple sclerosis (MS): an “in vitro” study | Maddalena | Ruggieri |
| EP1609 | Dimethyl fumarate treatment differentially impairs frequency and function of activated, mature B cells | Jan | Traub |
| EP1610 | Effect of dimethyl fumarate on the development of type-II innate immune cells and CNS-infiltration of M1 macrophages | Suhayl | Dhib Jalbut |
| EP1611 | Peginterferon beta-1a safety and efficacy in real-life clinical setting: a prospective, multicenter follow-up study | Rocco | Totaro |
| EP1612 | Analysis of therapeutic regimens and treatment switch patterns in specific clinical forms of multiple sclerosis using big data | Marie | Trad |
| EP1613 | Pharmacokinetics and pharmacodynamics of PEGylated interferon beta-1a in patients with relapsing-remitting multiple sclerosis in the randomized double-blind placebo-controlled study | Arina | Zinkina-Orikhan |
| EP1614 | Experience with Secukinumab in multiple sclerosis | Virginia | Meca-Lallana |
| EP1615 | Immunomodulatory molecules on plasmacytoid dendritic cell is associated with decreased neurofilament light in the cerebrospinal fluid of patients with multiple sclerosis treated with natalizumab | Leonilda Maria Barbosa | Santos |
| EP1616 | A retrospective observational study of rituximab in multiple sclerosis patients in Cyprus | Eleni | Leonidou |
| EP1617 | The S1P5 receptor is not down-modulated in response to selective agonists | Marc | Bigaud |
| EP1618 | Optimising Siponimod (BAF312) oral administration for long-term experimental studies in mice | Philipp | Albrecht |
| EP1619 | Phase 2 AFFINITY trial evaluates opicinumab in a targeted population of patients with relapsing multiple sclerosis: rationale, design and baseline characteristics | Bing | Zhu |
| EP1620 | Effect of MD1003 (high dose pharmaceutical grade biotin) on dexterity, cognitive, and quality of life measures in a cohort of patients with non-active progressive multiple sclerosis | Cecile | Donze |
| EP1621 | Disability stabilization in multiple sclerosis under teriflunomide treatment | Francesca | Sangalli |
| EP1622 | Treatment with dimethyl fumarate enhances cholinergic transmission in multiple sclerosis | Carolina G | Nicoletti |
| EP1623 | Remyelination promoting therapies in multiple sclerosis animal models: a systematic review and meta-analysis | Benjamin V. | Ineichen |
| EP1624 | A prospective study of disease modifying therapy and retinal atrophy in multiple sclerosis | Anna | Kabanovski |
| EP1625 | Frequency and description of relapses in a cohort of progressive multiple sclerosis patients treated with high dose biotin | Bruno | Brochet |
| EP1626 | Long-term effect of natalizumab in a French cohort of patients with RRMS: TYSTEN cohort | Kevin | Bigaut |
| EP1627 | Integration of ocrelizumab safety data from the German study CONFIDENCE into the global post-marketing safety studies MANUSCRIPT and VERISMO | Tjalf | Ziemssen |
| EP1628 | A comparison of efficacy of subcutaneous interferon beta-1a 44 µg, dimethyl fumarate and fingolimod in the real-life clinical practise, a multicenter observational study | Zbyšek | Pavelek |
| EP1629 | The BELTRIMS registry: real-world safety and efficacy of DMTs in Belgium | Barbara | Willekens |
| EP1630 | Prospective real world observational multi-center study in patients with relapsing-remitting multiple sclerosis treated with dimethyl fumarate in Campania, Italy | Roberta | Lanzillo |
| EP1631 | Clinical characteristics of relapsing-remitting multiple sclerosis patients with persistent lymphopenia with dimethyl fumarate and comparison with no lymphopenic patients | Rocío | López Ruiz |
| EP1632 | The potential influence of long term individualized patient coaching to optimize therapy management and address challenges in an individualized patient support program | Mathias | Mäurer |
| EP1633 | A Swedish nationwide pharmaco-epidemiological study of the long-term safety and effectiveness of teriflunomid (IMSE 4) | Selin | Safer Demirbüker |
| EP1634 | Early stages of disability in patients with multiple sclerosis by physician and patient-reported outcomes: a two-year study | Maria | Wunderlich |
| EP1635 | Autoimmune alopecia totalis; a complication of alemtuzumab therapy in multiple sclerosis | Wilson Ka Wai | Fung |
| EP1636 | A milestone in multiple sclerosis treatment: what changed in the landscape of the multiple sclerosis treatment with oral medications | Serkan | Ozakbas |
| EP1637 | Skin autoimmune problems following alemtuzumab treatment in multiple sclerosis | Maria | Ruiz de Arcos |
| EP1638 | Real life effectiveness and safety of teriflunomide in relapsing-remiting multiple sclerosis (RRMS): a MS reference center-based observational study with two years follow-up | Jose Eustasio | Meca Lallana |
| EP1639 | Real-world effectiveness and safety of pegylated interferon beta-1a in patients with multiple sclerosis: a multicentre retrospective study in Central Italy | Shalom | Haggiag |
| EP1640 | Real-world longitudinal data of peginterferon beta-1a from a Swedish national post-marketing surveillance study (IMSE 6) - efficacy and safety profile | Stina | Kågström |
| EP1641 | The Multiple Sclerosis Data Alliance: better data for better decision making, a multi-stakeholder approach | Liesbet M. | Peeters |
| EP1642 | Real world effectiveness of fingolimod in patients with relapsing remitting multiple sclerosis and non-response to previous treatment: a prospective analysis in Buenos Aires, Argentina | Juan | Rojas |
| EP1643 | Efficacy of alemtuzumab treatment in active RRMS - a real-life study | Ofir | zmira |
| EP1644 | Guillain-Barré syndrome after treatment with alemtuzumab in a patient with multiple sclerosis | Claudia | Balducci |
| EP1645 | Spanish registry of multiple sclerosis patients on glatiramer acetate 40 mg/ml treatment: real-world results and initial results of first year follow-up | Oscar | Fernandez |
| EP1646 | Real World Evidence (RWE) on impact of age on long-term persistence to disease modifying therapies (DMTs) in relapsing-remitting multiple sclerosis (RRMS) in Australia | Tim | Spelman |
| EP1647 | Very long term use of natalizumab is possible but carries a high burden | Elisa Matias Vieira | Melo |
| EP1648 | Patients switching to fingolimod in daily clinical routine: 2 year interim results from the non-interventional study PANGAEA 2.0 | Ulf | Schulze-Topphoff |
| EP1649 | Clinical protocol for the prevention of rebound phenomenon after natalizumab cessation in multiple sclerosis. A multiple sclerosis reference center experience | Luna | Fuentes Rumí |
| EP1650 | Evolving predictors to medication adherence in patients with MS - a prospective analysis with multiple indicators | Anat | Wolkovich |
| EP1651 | 17 - year adherence to interferon beta-1b treatment in patients with multiple sclerosis | Carmen Adella | Sirbu |
| EP1652 | Comparative efficacy of natalizumab and fingolimod in multiples sclerosis in a Tunisian population | Ahmed | Ghariani |
| EP1653 | Delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis - findings from a real-world setting in Russian Federation | Maria | Davydovskaya |
| EP1654 | Comparison of use oral and injection disease-modifying therapies in persons with multiple sclerosis | Taha | Aslan |
| EP1655 | Serious adverse events related to Rituximab in multiple sclerosis and neuromyelitis optica spectrum disorder patients | Lana | Zhovtis Ryerson |
| EP1656 | Quality of life improves with alemtuzumab over 6 years even in patients with relapsing-remitting multiple sclerosis who developed thyroid adverse events | Tjalf | Ziemssen |
| EP1657 | Daclizumab: side effects and efficacy in a real world setting | Sandra | Raunegger |
| EP1658 | Tuberculosis screening in the setting of multiple sclerosis disease modifying therapies | Laura | Baldassari |
| EP1659 | Patients' perception about risk and benefit in disease modifying therapies: an Italian multicentric survey | Mariavittoria | Turrini |
| EP1660 | Pharmacy-led prescribing of natalizumab in MS patients improves the quality of monitoring and overall safety | Rachel | Dorsey-Campbell |
| EP1661 | Effectiveness of reduced fingolimod dosage in relapsing remitting multiple sclerosis - a Portuguese cohort | Joana | Ramos Lopes |
| EP1662 | Disease-modifying treatment and infectious risk in patients with multiple sclerosis - the experience of a Portuguese tertiary care hospital | Daniela | Ferro |
| EP1663 | Tuberculosis screening in patients with multiple sclerosis who are candidates for natalizumab and fingolimod in a Portuguese tertiary centre | Sara | Duarte |
| EP1664 | Genomic profiling and in vivo rat toxicity characterization of Copaxone and the Synthon European follow-on glatiramer acetate product | Pippa | Loupe |
| EP1665 | Risk of pulmonary embolism in patients with multiple sclerosis on dimethyl fumarate | Gracy | Juba |
| EP1666 | Recurrent autoimmune uveitis after alemtuzumab treatment for multiple sclerosis | Erika | Portera |
| EP1667 | Prevalence of therapeutic inertia in multiple sclerosis care in Argentina: results from EDUCAR MS Argentina | Fernando | Caceres |
| EP1668 | Fingolimod cessation and multiple sclerosis rebound syndrome: a case report and literature review | Giordani | dos Passos |
| EP1669 | "We'll test your blood for an infection that might kill you" - a qualitative study describing how risks of disease modifying treatment are communicated to people with relapsing multiple sclerosis | Ana | Manzano |
| EP1670 | Early onset autoimmune manifestations after alemtuzumab treatment for multiple sclerosis: a single-center cohort study | Aglaia | Vakrakou |
| EP1671 | Hepatitis B reactivation in a patient with primary progressive multiple sclerosis under ocrelizumab treatment | Marco | Iannetta |
| EP1672 | A case of immune-mediated encephalitis related to daclizumab therapy | Stefan | Blum |
| EP1673 | Brain atrophy estimation from incomplete clinically-acquired MRI scans - a validation of the MS ´Frankenstein´ approach | Margareta | Clarke |
| EP1674 | Using label-free NAD(P)H-FLIM to monitor effect of teriflunomide on NOX enzyme activation in CNS cells | Helena | Radbruch |
| EP1675 | Deep learning for cell-specific high-throughput quantification of oligodendrocyte ensheathment | Jack | Antel |
| EP1676 | White matter diffusion and myelin integrity improvement after 6 months of fingolimod treatment in relapsing-remitting multiple sclerosis | Svetlana | Bezukladova |
| EP1677 | Evaluation of dimethylfumarate in treatment of focal DTH and MOG EAE using TSPO-PET imaging | Susanne K | Vainio |
| EP1678 | Comparative analysis of natalizumab versus fingolimod by including cortical lesions into NEDA-3 concept | Marco | Puthenparampil |
| EP1679 | PROMiS (a prospective, non-interventional study in US patients with relapsing-remitting multiple sclerosis treated with alemtuzumab in routine clinical practice): interim results on treatment history and satisfaction with alemtuzumab | Bhupendra O | Khatri |
| EP1680 | Elevated neurofilament light chain levels in progressive multiple sclerosis effectively reduced by cladribine treatment | Ozlem | Yildiz |
| EP1681 | Tolerability and persistence in therapy with PEGylated-IFN: results from a multicentric observational study in northern Italy | Pietro | Annovazzi |
| EP1682 | Comparative efficacies of dimethyl fumarate and fingolimod in quantitative radiographic disease measures using clinical MRI | Jenny | Feng |
| EP1683 | Favorable response to disease modifying treatments in Chinese patients with relapsing multiple sclerosis - results from a prospective registry in Hong Kong | Chung Kwan | Au |
| EP1684 | Italian botulinum toxin network study on the management of spasticity in multiple sclerosis | Marcello | Moccia |
| EP1685 | “I'm in a very good frame of mind”: the experience of standing frame use in people with progressive multiple sclerosis | Louise | Jarrett |
| EP1686 | Biofeedback based home balance training can improve balance but not gait in people with multiple sclerosis | Klara | Novotna |
| EP1687 | Does cognitive training improve attention/working memory in persons with MS? A pilot study using the Cogmed Working Memory Training program | Sarah Anne | Morrow |
| EP1688 | Implementing cognitive rehabilitation for people with multiple sclerosis: translating research into clinical practice | Jacqueline R | Mhizha-Murira |
| EP1689 | Medical and recreational cannabis use in patients with multiple sclerosis in Denmark | Stefan | Gustavsen |
| EP1690 | A prospective observational registry of repository corticotropin injection for the treatment of multiple sclerosis relapse: baseline characteristics and updated interim results | Bryan | Due, PhD |
| EP1691 | Work out training, coordination training and an active control condition improved subjective sleep, fatigue and symptoms of depression and anxiety among female patients with multiple sclerosis (MS) | Dena | Sadeghi Bahmani |
| EP1692 | Intrathecal phenol is a forgotten treatment option for severe lower limb spasticity in advanced multiple sclerosis | Sara | Simeoni |
| EP1693 | Evaluation of the cognitive benefits of intrathecal baclofen pump implantation in subjects with intractable MS related spasticity | Rachel | Farrell |
| EP1694 | THC/CBD oromucosal spray in patients with multiple sclerosis bladder dysfunction: a pilot prospective study | Valentina | Torri Clerici |
| EP1696 | A survey of cannabis-based product use in multiple sclerosis patients at the University of British Columbia Hospital | Alice Jane | Schabas |
| EP1697 | Acute aphasia responsive to tissue plasminogen activator in an 8-week pregnant multiple sclerosis patient after discontinuation of fingolimod | Brian | Barry |
| EP1698 | Efficacy and discontinuation of nabiximols in patients with multiple sclerosis: a real-life study | Valeria | Bergamaschi |
| EP1699 | The impact of treating obstructive sleep apnoea syndrome on cognitive function in people with multiple sclerosis | Nuala | McNicholas |
| EP1700 | The effect of pilates exercise on balance, postural instability, functional capacity and quality of life in multiple sclerosis patients | Nur | Yüceyar |
| EP1701 | Intrathecal baclofen should be considered in ambulatory people with multiple sclerosis related spasticity: an observational study | Yezen | Sammaraiee |
| EP1702 | Substantial improvement of walking after fampridine introduction indicates improvement of meaningful and self-chosen activities of daily living in patients with multiple sclerosis | Gregor | Brecl Jakob |
| EP1703 | Virtual reality training to improve upper limb motor function in multiple sclerosis: a feasibility study protocol | Alon | Kalron |
| EP1704 | The influence of multiple sclerosis therapies on headache | Yesim | Beckmann |
| EP1705 | Physicians' gender differences in risk perception and therapeutic inertia in multiple sclerosis care | Gustavo | Saposnik |
| EP1706 | Early experience with ocrelizumab: patient characteristics from a large insurance claims database | Natalie J | Engmann |
| EP1707 | Closing the gaps for MS treatment adherence at low middle income countries. Egypt case | Abdalla | Abotaleb |
| EP1708 | Locked-in-syndrome in a patient with tumefactive multiple sclerosis | Frank | Thömke |
| EP1709 | Self-esteem partially mediates the relationship between quality of life and depression in multiple sclerosis patients | Egemen | İdiman |
| EP1710 | Online medical education improves knowledge of immune mechanisms in the treatment of MS among neurologists | Thomas | Finnegan |
| EP1711 | A global nurse-focused Delphi approach to management of gastrointestinal tolerability of dimethyl fumarate | Trudy L. | Campbell |
| EP1712 | Is the primary use of generic (non-propietary) disease modifying therapies (DMTs) associated with therapeutic inertia in multiple sclerosis care? | Fernando | Caceres |
| EP1713 | Pilates exercise has positive effect on balance but not on gait performance in people with mild multiple sclerosis | Klara | Novotna |
| EP1714 | 1 year-healthy outcomes in RRMS patients treated with teriflunomied and dimethyl fumarate | Inés | González-Suárez |
| EP1715 | TeleSEP: development of platform to regional tele-expertise in multiple sclerosis | Nathalie | Derache |
| EP1716 | Is itIt's possible to continue a really effective therapy in a patient with a severe hypersensitivity drug reaction? The importance of desensitization procedures in the monoclonal antibodies era | Lucia | Moiola |
| EP1717 | High-dose biotin in progressive multiple sclerosis : a prospective study of 86 patients in routine clinical practice | Laura | Couloume |
| EP1718 | Treatment of spasticity in patients with multiple sclerosis by using method of electrical stimulation according to Jantsch - a pilot study | Martina | Kovari |
| EP1719 | MS in the 21st Century mapping study identifying the global educational offerings for multiple sclerosis patients | Sven | Schippling |
| EP1720 | Wind of change: an Italian initiative to promote water sports in people with multiple sclerosis | Andrea | Tacchino |
| EP1721 | Is placebo effect getting bigger in randomized controlled trials of multiple sclerosis? | Murat | Kurtuncu |
| EP1722 | Making science digestible: the development of educational activities for children with a parent with MS, and the need to better engage families | Alison | Thomson |
| EP1723 | Young MS in Italy: attitude towards present and expectations for the future | Mario Alberto | Battaglia |
| EP1724 | Attendance to ECTRIMS: does it impact on therapeutic decisions in multiple sclerosis care? | Gustavo | Saposnik |
| EP1725 | Fulminant multifocal relapse in a fingolimod-treated patient | Agustina M. | Lascano |
| EP1726 | Demographic and clinical characteristics of patients treated with ocrelizumab in the United States | Natalie J | Engmann |
| EP1727 | Effect of pregnancy and exclusive breastfeeding on the rate of relapses and degree of disability in two years after pregnancy in patients with multiple sclerosis | Mehran | Ghaffari |
| EP1728 | Fuelling patient engagement in health: perceptions and utilisation of patient self-monitoring | Hannah | Brown |
| EP1729 | Idiopathic thrombocytopenic purpura (ITP) during Fingolimod treatment in relapsing remitting multiple sclerosis | Negar | Molazadeh |
| EP1730 | Digging up a new approach in the management of multiple sclerosis: Helminth therapy from the patients' perspective | Megan C | Kirkland |
| EP1731 | A comparison of the effects of yoga and clinical pilates exercise on mobility, respiratory muscle strength and cognition in persons with multiple sclerosis | Zuhal | Abasiyanik |
| EP1732 | EDSS score, age, disease type and inaccessibility impact on oral health and prosthodontic rehabilitation in multiple sclerosis patients of a Hellenic cohort | Maria | Anagnostouli |
| EP1733 | The main factors that influence the family life of patients with multiple sclerosis | Ionela A. | Ionescu |
| EP1734 | Hepatitis B post-vaccination immunogenicity in multiple sclerosis patients undergoing immunomodulators | Silvia | Presas-Rodriguez |
| EP1735 | Methylprednisolone concentration in milk and serum during and shortly after IV pulse therapy in patients with MS | Cavit | Boz |
| EP1736 | Effects of methyl prednisolone on the proliferation and maturation of oligodentrocytes. In vitro study | Paloma | Montero-Escribano |
| EP1737 | Real-world effectiveness of TYSABRI® (natalizumab) treatment in patients with relapsing remitting multiple sclerosis in Argentina and Chile | Célica | Ysrraelit |
| EP1738 | Multiple sclerosis prognosis - our experience in Colentina Clinical Hospital | Oana | Rujan |